Literature DB >> 31297749

Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis.

Paolo Cameli1, Alfonso Carleo2, Laura Bergantini3, Claudia Landi3, Antje Prasse2, Elena Bargagli3.   

Abstract

Idiopathic pulmonary fibrosis is characterised by abnormal reepithelialisation and remodelling consequent to persistent stimuli or injury. The involvement of oxidative stress in alveolar injury, inflammation and fibrosis development has been suggested. Increased concentrations of lipid peroxidation products, oxidised proteins and an altered antioxidant enzyme status with the depletion of glutathione, the most abundant low-molecular-weight antioxidant, have often been reported in epithelial lining fluid of IPF patients. This review describes the sources of free radical generation, ROS-induced signalling pathways and mechanisms of oxidative stress damages in the pathogenesis of idiopathic pulmonary fibrosis.

Entities:  

Keywords:  idiopathic pulmonary fibrosis; oxidant/antioxidant balance; oxidative stress; pathogenesis

Mesh:

Substances:

Year:  2020        PMID: 31297749     DOI: 10.1007/s10753-019-01059-1

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  55 in total

1.  Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis.

Authors:  Paola Rottoli; Barbara Magi; Riccardo Cianti; Elena Bargagli; Cecilia Vagaggini; Nikolaos Nikiforakis; Vitaliano Pallini; Luca Bini
Journal:  Proteomics       Date:  2005-07       Impact factor: 3.984

2.  Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis.

Authors:  A Carleo; E Bargagli; C Landi; D Bennett; L Bianchi; A Gagliardi; C Carnemolla; M G Perari; G Cillis; A Armini; L Bini; P Rottoli
Journal:  J Breath Res       Date:  2016-04-15       Impact factor: 3.262

3.  Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis.

Authors:  D Saleh; P J Barnes; A Giaid
Journal:  Am J Respir Crit Care Med       Date:  1997-05       Impact factor: 21.405

4.  Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.

Authors:  Lutz Wollin; Isabelle Maillet; Valérie Quesniaux; Alexander Holweg; Bernhard Ryffel
Journal:  J Pharmacol Exp Ther       Date:  2014-02-20       Impact factor: 4.030

5.  Role of inducible nitric oxide synthase-derived nitric oxide in silica-induced pulmonary inflammation and fibrosis.

Authors:  Patti Zeidler; Ann Hubbs; Lori Battelli; Vincent Castranova
Journal:  J Toxicol Environ Health A       Date:  2004-07-09

6.  iNOS gene upregulation is associated with the early proliferative response of human lung fibroblasts to cytokine stimulation.

Authors:  Hanna M Romanska; Julia M Polak; Robert A Coleman; Rowena S James; Daniel W Harmer; Jennifer C Allen; Anne E Bishop
Journal:  J Pathol       Date:  2002-07       Impact factor: 7.996

7.  Oxidative Stress and Therapeutic Development in Lung Diseases.

Authors:  Leah Villegas; Timothy Stidham; Eva Nozik-Grayck
Journal:  J Pulm Respir Med       Date:  2014-07-15

Review 8.  Oxidative stress, aging, and diseases.

Authors:  Ilaria Liguori; Gennaro Russo; Francesco Curcio; Giulia Bulli; Luisa Aran; David Della-Morte; Gaetano Gargiulo; Gianluca Testa; Francesco Cacciatore; Domenico Bonaduce; Pasquale Abete
Journal:  Clin Interv Aging       Date:  2018-04-26       Impact factor: 4.458

Review 9.  Lung extracellular matrix and redox regulation.

Authors:  Walter H Watson; Jeffrey D Ritzenthaler; Jesse Roman
Journal:  Redox Biol       Date:  2016-02-18       Impact factor: 11.799

10.  Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation.

Authors:  Jungnam Lee; Ivan Arisi; Ermanno Puxeddu; Lazarus K Mramba; Massimo Amicosante; Carmen M Swaisgood; Marco Pallante; Mark L Brantly; C Magnus Sköld; Cesare Saltini
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

View more
  22 in total

1.  Inhibition of oxidative stress induced-cytotoxicity by coptisine in V79-4 Chinese hamster lung fibroblasts through the induction of Nrf-2 mediated HO-1 expression.

Authors:  Hyeon-Gyun Jo; Cheol Park; Hyesook Lee; Gi-Young Kim; Young-Sam Keum; Jin Won Hyun; Taeg Kyu Kwon; Yung Hyun Choi; Su Hyun Hong
Journal:  Genes Genomics       Date:  2020-11-25       Impact factor: 1.839

2.  Ameliorative Effects of Arctigenin on Pulmonary Fibrosis Induced by Bleomycin via the Antioxidant Activity.

Authors:  Yueshang Wang; Xinpeng Li; Shiwen Pu; Xiao Wang; Lanping Guo; Lisheng Zhang; Zhen Wang
Journal:  Oxid Med Cell Longev       Date:  2022-07-05       Impact factor: 7.310

Review 3.  A review for natural polysaccharides with anti-pulmonary fibrosis properties, which may benefit to patients infected by 2019-nCoV.

Authors:  Rui-Rong Chen; Ya-Jun Li; Jun-Jia Chen; Chuan-Li Lu
Journal:  Carbohydr Polym       Date:  2020-07-07       Impact factor: 9.381

4.  The HSP90 Inhibitor, AUY-922, Ameliorates the Development of Nitrogen Mustard-Induced Pulmonary Fibrosis and Lung Dysfunction in Mice.

Authors:  Pavel Solopov; Ruben M L Colunga Biancatelli; Margarita Marinova; Christiana Dimitropoulou; John D Catravas
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

Review 5.  MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases.

Authors:  Montserrat Climent; Giacomo Viggiani; Ya-Wen Chen; Gerald Coulis; Alessandra Castaldi
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

Review 6.  Telomere Abnormalities in the Pathobiology of Idiopathic Pulmonary Fibrosis.

Authors:  Hasancan Bilgili; Adam J Białas; Paweł Górski; Wojciech J Piotrowski
Journal:  J Clin Med       Date:  2019-08-16       Impact factor: 4.241

7.  Serum heme oxygenase-1 measurement is useful for evaluating disease activity and outcomes in patients with acute respiratory distress syndrome and acute exacerbation of interstitial lung disease.

Authors:  Ryo Nagasawa; Yu Hara; Kota Murohashi; Ayako Aoki; Nobuaki Kobayashi; Shigeto Takagi; Satoru Hashimoto; Akihiko Kawana; Takeshi Kaneko
Journal:  BMC Pulm Med       Date:  2020-11-25       Impact factor: 3.317

8.  Proteome Characterization of BALF Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Unveiling Undercover Molecular Pathways.

Authors:  Enxhi Shaba; Claudia Landi; Alfonso Carleo; Lorenza Vantaggiato; Eugenio Paccagnini; Mariangela Gentile; Laura Bianchi; Pietro Lupetti; Elena Bargagli; Antje Prasse; Luca Bini
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

9.  Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases.

Authors:  Laura Bergantini; Miriana d'Alessandro; Lucia Vietri; Giuseppe Domenico Rana; Paolo Cameli; Silvia Acerra; Piersante Sestini; Elena Bargagli
Journal:  Immunol Res       Date:  2020-10-22       Impact factor: 2.829

10.  Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice.

Authors:  Jizhen Huang; Xiang Tong; Li Zhang; Yuan Zhang; Lei Wang; Dongguang Wang; Shijie Zhang; Hong Fan
Journal:  Front Pharmacol       Date:  2020-10-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.